• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分支型O-聚糖的生物合成。

The biosynthesis of branched O-glycans.

作者信息

Schachter H, Brockhausen I

机构信息

Department of Biochemistry, University of Toronto, Ontario, Canada.

出版信息

Symp Soc Exp Biol. 1989;43:1-26.

PMID:2701469
Abstract

The hypothesis put forward in this review is that the branching patterns at the core of Ser(Thr)-GalNAc oligosaccharides (O-glycans) determine the types of glycan that are synthesized and their functions. Biosynthetic pathways are presented for the four types of O-glycan core and for some of the more common glycans that are built on these cores. The four core types discussed are: (1) Gal beta 1-3GalNAc-alpha-Ser(Thr)-R, (2) Gal beta 1-3(GlcNAc beta 1-6)GalNAc-alpha-Ser(Thr)-R, (3) GlcNAc beta 1-3GalNAc-alpha-Ser(Thr)-R, and (4) GlcNAc beta 1-3(GlcNAc beta 1-6)GalNAc-alpha-Ser(Thr)-R. General rules concerning the control of synthesis of these molecules are derived.

摘要

本综述提出的假设是,丝氨酸(苏氨酸)-N-乙酰半乳糖胺寡糖(O-聚糖)核心处的分支模式决定了所合成聚糖的类型及其功能。文中展示了四种O-聚糖核心以及基于这些核心构建的一些更常见聚糖的生物合成途径。所讨论的四种核心类型为:(1)Galβ1-3GalNAc-α-Ser(Thr)-R,(2)Galβ1-3(GlcNAcβ1-6)GalNAc-α-Ser(Thr)-R,(3)GlcNAcβ1-3GalNAc-α-Ser(Thr)-R,以及(4)GlcNAcβ1-3(GlcNAcβ1-6)GalNAc-α-Ser(Thr)-R。由此得出了关于这些分子合成控制的一般规则。

相似文献

1
The biosynthesis of branched O-glycans.分支型O-聚糖的生物合成。
Symp Soc Exp Biol. 1989;43:1-26.
2
Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.正常供体和白血病患者白细胞中O-聚糖的生物合成:白血病细胞中O-聚糖核心2 UDP-葡萄糖胺:半乳糖β3 N-乙酰半乳糖胺α-R(从葡萄糖胺到N-乙酰半乳糖胺)β(1-6)-N-乙酰葡糖胺基转移酶增加。
Cancer Res. 1991 Feb 15;51(4):1257-63.
3
Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.糖基转移酶在人结肠腺癌CaCo-2细胞分化过程中的变化。
Cancer Res. 1991 Jun 15;51(12):3136-42.
4
Synthetic studies on the carbohydrate moiety of the antigen from the parasite Echinococcus multilocularis.多房棘球绦虫寄生虫抗原碳水化合物部分的合成研究。
Carbohydr Res. 2009 May 12;344(7):856-68. doi: 10.1016/j.carres.2009.02.019. Epub 2009 Feb 24.
5
Unbranched polylactosamino-O-glycans on human skim milk mucins exhibit Gal beta(1-4)GlcNAc beta(1-6) repeating units.人脱脂乳粘蛋白上的直链聚乳糖胺 - O - 聚糖呈现出Galβ(1-4)GlcNAcβ(1-6)重复单元。
Symp Soc Exp Biol. 1989;43:155-62.
6
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.O-聚糖核心1(Galβ1-3GalNAcα-R)的加工。核心2的特异性,UDP-N-乙酰葡糖胺:Galβ1-3GalNAc-R(从GlcNAc到GalNAc)β6-N-乙酰葡糖胺基转移酶和CMP-唾液酸:Galβ1-3GalNAc-Rα3-唾液酸转移酶。
Glycoconj J. 1993 Oct;10(5):381-94. doi: 10.1007/BF00731043.
7
Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.人类血型H基因指定的α1,2-L-岩藻糖基转移酶对硫酸化/唾液酸化/岩藻糖基化受体的特异性表征:Gal的α1,2-L-岩藻糖基化与天冬酰胺连接的GlcNAc的α1,6-L-岩藻糖基化之间呈负相关的证据。
Biochemistry. 1996 Jul 9;35(27):8914-24. doi: 10.1021/bi952193m.
8
[Primary structure of the glycan chains of normal C 1 esterase inhibitor (C 1-INH) after NMR analysis at 400 MHz].[在400兆赫核磁共振分析后正常C1酯酶抑制剂(C1-INH)聚糖链的一级结构]
C R Acad Sci III. 1985;301(11):571-6.
9
Differential binding properties of Gal/GalNAc specific lectins available for characterization of glycoreceptors.可用于糖受体表征的半乳糖/ N - 乙酰半乳糖胺特异性凝集素的差异结合特性。
Indian J Biochem Biophys. 1997 Feb-Apr;34(1-2):61-71.
10
Alterations of O-glycan biosynthesis in human colon cancer tissues.人结肠癌组织中O-聚糖生物合成的改变。
Glycobiology. 1994 Dec;4(6):873-84. doi: 10.1093/glycob/4.6.873.

引用本文的文献

1
Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery.人类疾病中的糖组学及其在生物标志物发现中的新兴作用。
Biomedicines. 2025 Aug 21;13(8):2034. doi: 10.3390/biomedicines13082034.
2
Sweet Aging: Glycocalyx and Galectins in CNS Aging and Neurodegenerative Disorders.甜蜜的衰老:中枢神经系统衰老和神经退行性疾病中的糖萼与半乳糖凝集素
Int J Mol Sci. 2025 May 14;26(10):4699. doi: 10.3390/ijms26104699.
3
Altered O-linked glycosylation in benign and malignant meningiomas.良性和恶性脑膜瘤中O-连接糖基化的改变。
PeerJ. 2024 Jan 22;12:e16785. doi: 10.7717/peerj.16785. eCollection 2024.
4
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.癌症中的糖基化改变:生物标志物和治疗的有希望的靶点。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188464. doi: 10.1016/j.bbcan.2020.188464. Epub 2020 Nov 4.
5
Increased Expression of Immature Mannose-Containing Glycoproteins and Sialic Acid in Aged Mouse Brains.衰老小鼠脑中不成熟含甘露糖糖蛋白和唾液酸表达增加。
Int J Mol Sci. 2019 Dec 4;20(24):6118. doi: 10.3390/ijms20246118.
6
A novel assay for detection and quantification of C-mannosyl tryptophan in normal or diabetic mice.一种用于检测和定量正常或糖尿病小鼠中 C-甘露糖基色氨酸的新方法。
Sci Rep. 2019 Mar 18;9(1):4675. doi: 10.1038/s41598-019-41278-y.
7
Improving Immunotherapy Through Glycodesign.通过糖基设计提高免疫疗法。
Front Immunol. 2018 Nov 2;9:2485. doi: 10.3389/fimmu.2018.02485. eCollection 2018.
8
Regulation of T Cell Trafficking by Enzymatic Synthesis of O-Glycans.O-聚糖酶促合成对T细胞转运的调控
Front Immunol. 2017 May 24;8:600. doi: 10.3389/fimmu.2017.00600. eCollection 2017.
9
Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.白细胞与内皮选择素的配体:在流动状态下介导滚动和信号转导的特化糖缀合物。
Blood. 2011 Dec 22;118(26):6743-51. doi: 10.1182/blood-2011-07-343566. Epub 2011 Oct 20.
10
Computational prediction of O-linked glycosylation sites that preferentially map on intrinsically disordered regions of extracellular proteins.O-连接糖基化位点的计算预测,这些位点优先定位在细胞外蛋白质的内在无序区域。
Int J Mol Sci. 2010;11(12):4991-5008. doi: 10.3390/ijms11124991. Epub 2010 Dec 3.